SCHEMBL8974873

SCHEMBL8974873

O=C(CC[CH]F)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.57
▸ TDP1 Q9NUW8 3/20 0.57
▸ MAPT P10636 3/20 0.57
▸ LMNA P02545 3/20 0.57
▸ NR4A2 P43354 1/20 0.57
▸ MAPK1 P28482 3/20 0.52
▸ SMN1; SMN2 Q16637 3/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ HPGD P15428 2/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ ALOX15 P16050 1/20 0.52
▸ CES1 P23141 1/20 0.52
▸ HDAC1 Q13547 5/20 0.52
▸ HDAC8 Q9BY41 5/20 0.52
▸ ALDH1A1 P00352 3/20 0.52
▸ GAA P10253 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ HDAC3 O15379 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7203020 0.84 TDP1 (0.53) L3MBTL1TDP1MAPTLMNANR4A2
SCHEMBL276676 0.81 NR4A2 (0.65) L3MBTL1TDP1MAPTLMNANR4A2
SCHEMBL719034 0.79 NR4A2 (0.85) L3MBTL1TDP1MAPTLMNANR4A2
SCHEMBL30121738 0.79 NR4A2 (0.85) L3MBTL1TDP1MAPTLMNANR4A2
SCHEMBL28180778 0.79 L3MBTL1 (0.57) L3MBTL1TDP1MAPTLMNANR4A2
SCHEMBL317112 0.79 MAPT (0.57) L3MBTL1TDP1MAPTLMNANR4A2
SCHEMBL8608674 0.79 TDP1 (0.57) L3MBTL1TDP1MAPTLMNANR4A2
SCHEMBL7324959 0.79 TDP1 (0.52) L3MBTL1TDP1MAPTLMNANR4A2
SCHEMBL18755271 0.78 NR4A2 (0.68) L3MBTL1TDP1MAPTLMNANR4A2
SCHEMBL9211933 0.78 TDP1 (0.56) L3MBTL1TDP1MAPTLMNANR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0543919-B1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS IN THE MANUFACTURE OF A MEDICAMENT FOR TREATMENT OF CNS DISEASES SEARLE & CO (US) 1996-04-10 — — EP claimed
EP-0543919-A1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS FOR TREATMENT OF CNS DISEASES. SEARLE & CO (US) 1993-06-02 — — EP claimed
WO-1992003131-A1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS FOR TREATMENT OF CNS DISEASES G.D. SEARLE & CO. (US) 1992-03-05 — — WO claimed
US-4173636-A Decahydroquinolines, pharmaceutical compositions and methods of use LABAZ (FR) 1979-11-06 — — US claimed
EP-0002283-A1 Substituted 1,3-dihydrospiro (benzo(c)thiophenes), process for their preparation and these compounds for use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1979-06-13 — — EP claimed
EP-0543919-B1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS IN THE MANUFACTURE OF A MEDICAMENT FOR TREATMENT OF CNS DISEASES SEARLE & CO (US) 1996-04-10 — — EP disclosed
US-5462965-A Use of heterocyclic amino-alcohol compounds for treatment of CNS diseases GD SEARLE & CO. (US) 1995-10-31 — — US disclosed
EP-0543919-A1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS FOR TREATMENT OF CNS DISEASES. SEARLE & CO (US) 1993-06-02 — — EP disclosed
WO-1992003131-A1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS FOR TREATMENT OF CNS DISEASES G.D. SEARLE & CO. (US) 1992-03-05 — — WO disclosed
US-4301292-A 1-[2-(4,5-Dihydro-4,4-dialkyl-2-oxazolyl)phenyl]-4-(dialkylamino)cyclohexanol HOECHST-ROUSSEL PHARMACEUTICALS, INCORPORATED (US) 1981-11-17 — — US disclosed
US-4292243-A 3\"-Phenyldispiro[1,3-dioxolane-2,4'-cyclohexane-1',1\"-(3\"H)-isobenzofuran] HOECHST ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1981-09-29 — — US disclosed
US-4292245-A 3'-Phenylspiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-one HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1981-09-29 — — US disclosed
US-4290958-A Spiro[cyclohexane-1,1'(3'H)-isobenzofuran]s HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1981-09-22 — — US disclosed
US-4288623-A 1-Aryl-4-amino-cyclohexan-1-ols HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1981-09-08 — — US disclosed
EP-0029286-A1 Pyrrolo(3,4-c)quinoline derivatives, processes therefor, and pharmaceutical compositions ICI AMERICAS INC. (US) 1981-05-27 — — EP disclosed
EP-0027522-A1 Spiro(cyclohexane-1,1'(3'H)-isobenzofuran)s, processes and intermediates for their preparation and pharmaceutical compositions containing them HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1981-04-29 — — EP disclosed
US-4263317-A Spiro[cyclohexane-1,1'(3'H)-isobenzofuran]s HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1981-04-21 — — US disclosed
US-4064128-A SEDATIVES KALI-CHEMIE AKTIENGESELLSCHAFT (DT) 1977-12-20 — — US disclosed
US-4022786-A PHARMACEUTICALS, CNS STIMULANT BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DT) 1977-05-10 — — US disclosed
US-4016280-A 4,4-Diarylpiperidine compositions and use BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DT) 1977-04-05 — — US disclosed
Send feedback